Neuland Laboratories News and Updates

Keep track of all breaking news on Neuland Laboratories from all sources in a single place.

25 Nov 2025

16674.00

3.71%

Neuland, Lupin, Divi's lead domestic, CDMO surge amid US generics headwinds

Business Standard

Analysts noted that while US generics face margin headwinds, domestic formulations and CDMOs remain resilient. Biosimilars are also poised for growth through new launches and regulatory support.

Neuland Laboratories Ltd. is trading below its 30 day SMA of 16861.0

Neuland Laboratories Ltd.

07 Nov 2025

16674.00

3.71%

to see Rapid results content

Neuland Laboratories Ltd.

31 Jul 2025

16674.00

3.71%

to see Rapid results content

Neuland Laboratories Ltd.

14 Jul 2025

16674.00

3.71%

Neuland Laboratories shares jump 12% ahead of final dividend

Economic Times

Neuland Laboratories shares are experiencing a surge, trading 12% higher. This increase comes as investors anticipate a final dividend of Rs 12 per share. The record date for dividend eligibility is July 18, 2025. Technically, the stock shows a strong bullish trend. It trades above all analyzed Simple Moving Averages. The Relative Strength Index indicates neither oversold nor overbought conditions.

Neuland Laboratories Ltd.'s price crossed above 30Day SMA today

Mukul Agrawal portfolio pharmaceutical stock surges 10% in weak market

Business Standard | 14 Jul 2025

Neuland Laboratories Ltd.

30 Jun 2025

16674.00

3.71%

Market attentionwill be on these 5 Pharma stocks on Monday, June 30, 2025

Business Line

JB Pharma-Torrent deal, USFDA's observation on Alembic, Granules and Neuland

Neuland Laboratories Ltd. is trading below its 30 day SMA of 16861.0

Neuland Laboratories Ltd.

15 May 2025

16674.00

3.71%

Neuland Laboratories Results Earnings Call for Q4FY25 & Full Year

Conference Call with Neuland Laboratories Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.

audio